{
  "ticker": "LLY",
  "target_date": "2025-10-20",
  "actual_date": "2025-10-20",
  "collected_at": "2025-12-08T12:25:36.073646",
  "price": {
    "open": 804.42,
    "high": 808.22,
    "low": 798.6,
    "close": 807.7737426757812,
    "volume": 2279700,
    "change_1d_pct": 0.76,
    "change_7d_pct": -5.42,
    "change_30d_pct": 9.52
  },
  "technicals": {
    "rsi_14": 61.88,
    "sma_20": 799.59,
    "sma_50": 753.5,
    "macd": 17.631,
    "macd_signal": 21.355,
    "macd_histogram": -3.723,
    "bb_upper": 891.77,
    "bb_lower": 707.42,
    "price_vs_sma20_pct": 1.02,
    "price_vs_sma50_pct": 7.2,
    "volume_ratio": 0.63
  },
  "fundamentals": {
    "market_cap": 894305239040,
    "pe_ratio": 48.878,
    "forward_pe": 44.02471,
    "price_to_book": 37.56024,
    "price_to_sales": 15.050627,
    "profit_margin": 30.99,
    "operating_margin": 48.29,
    "roe": 96.47,
    "roa": 17.6,
    "revenue_growth": 53.9,
    "earnings_growth": 480.4,
    "debt_to_equity": 178.516,
    "current_ratio": 1.546,
    "quick_ratio": 0.724,
    "dividend_yield": 59.0,
    "fifty_two_week_high": 1111.99,
    "fifty_two_week_low": 623.78,
    "fifty_day_avg": 911.5326,
    "two_hundred_day_avg": 811.9354,
    "analyst_target": 1056.7045,
    "analyst_recommendation": "buy",
    "num_analysts": 27,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -10.29,
    "pct_from_52w_low": 59.93
  },
  "macro": {
    "spy": {
      "price": 671.3,
      "change_1d_pct": 1.04,
      "change_7d_pct": 2.8
    },
    "vix": {
      "level": 18.23,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 3.99
    },
    "dollar_index": {
      "level": 98.59
    },
    "gold": {
      "price": 4336.4
    },
    "regime": "BULL_NORMAL"
  },
  "news": [
    {
      "headline": "Hims & Hers: Q3 Could Provide Volatility, But The Long-Term Vision Remains Bright",
      "source": "SeekingAlpha",
      "datetime": 1760990823,
      "summary": "Discover how Hims & Hers Health, Inc. is disrupting the obesity drug market amid regulatory changes. Learn what investors should know now. Click for more on HIMS.",
      "url": "https://finnhub.io/api/news?id=514a240f3b8c403dc1c37a5d965dad6517b50e88d5d1c94bbbdd159413993065"
    },
    {
      "headline": "RANI: Chugai Deal Announced",
      "source": "Yahoo",
      "datetime": 1760972760,
      "summary": "By John Vandermosten, CFA NASDAQ:RANI READ THE FULL RANI RESEARCH REPORT With investors perched on the edge of their seats for months, Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) announces a deal including upfront milestones and partner-funded asset development. On October 18 th Rani and Chugai P",
      "url": "https://finnhub.io/api/news?id=e7bb4fa5366528cb12c0e5afd0ca6e855f944635018b2704491377c46f64004f"
    },
    {
      "headline": "Rani Therapeutics: Initiating At Buy On Promising RaniPill Advancement With Chugai",
      "source": "SeekingAlpha",
      "datetime": 1760970015,
      "summary": "Rani Therapeutics secured a $1.085 billion collaboration with Chugai Pharmaceutical. Check out why I am initiating with a Buy rating on RANI stock.",
      "url": "https://finnhub.io/api/news?id=36347ac5912198470ef5396583d7edf28434e74c3f7179483889fa5c4a692083"
    },
    {
      "headline": "My Top 3 Pharma Stocks",
      "source": "SeekingAlpha",
      "datetime": 1760960303,
      "summary": "Discover the top 3 Big Pharma stocks beating forecasts and offering high dividends.",
      "url": "https://finnhub.io/api/news?id=16b7d42a7ab56fff4cf263eccf8bc6b046116accec4a8334c5f7f3ce0f4d8cee"
    },
    {
      "headline": "ESMO 2025: Eli Lilly\u2019s Verzenio extends survival in high-risk early breast cancer",
      "source": "Yahoo",
      "datetime": 1760958154,
      "summary": "These Phase III results could enhance Verzenio\u2019s uptake alongside ET in the adjuvant breast cancer setting, if approved.",
      "url": "https://finnhub.io/api/news?id=c37a61be624b1a13a5fb515b6b8eab015e04a8fb8b7020ebd95a877ece503b86"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-10-14",
      "description": "xslF345X05/form4-10142025_041001.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000037/xslF345X05/form4-10142025_041001.xml"
    },
    {
      "form": "4",
      "date": "2025-10-10",
      "description": "xslF345X05/form4-10102025_041001.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000035/xslF345X05/form4-10102025_041001.xml"
    },
    {
      "form": "4",
      "date": "2025-10-09",
      "description": "xslF345X05/form4-10092025_041002.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000031/xslF345X05/form4-10092025_041002.xml"
    },
    {
      "form": "4",
      "date": "2025-10-08",
      "description": "xslF345X05/form4-10082025_041001.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000029/xslF345X05/form4-10082025_041001.xml"
    },
    {
      "form": "4",
      "date": "2025-10-07",
      "description": "xslF345X05/form4-10072025_041001.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000031601125000027/xslF345X05/form4-10072025_041001.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}